Preoperative Sarcopenia Severity and Clinical Outcomes after Total Hip Arthroplasty.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
29 Jun 2024
Historique:
received: 27 05 2024
revised: 23 06 2024
accepted: 27 06 2024
medline: 13 7 2024
pubmed: 13 7 2024
entrez: 13 7 2024
Statut: epublish

Résumé

The outcome of total hip arthroplasty (THA) in patients with end-stage arthritis of the hip is associated with preoperative physical status. This study was performed to examine the relationship between the preoperative severity of sarcopenia and clinical outcomes after THA. This retrospective cohort study was performed among 306 consecutive patients (mean age: 63.7 ± 12.9 years, 222 women) undergoing THA at a university hospital. The severity of sarcopenia was determined based on the skeletal muscle mass index (SMI), handgrip strength, and gait speed according to the criteria of the Asian Working Group for Sarcopenia 2019. The severe sarcopenia prevalence rate was 10.6%. Severe sarcopenia was significantly associated with the risk of delayed functional recovery (adjusted odds ratio, 2.82; 95% confidence interval, 1.03-7.72;

Identifiants

pubmed: 38999833
pii: nu16132085
doi: 10.3390/nu16132085
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 24K20527
Organisme : Aichi Society for Physical Therapy
ID : NA

Auteurs

Shinya Tanaka (S)

Department of Rehabilitation, Nagoya University Hospital, Nagoya 466-8560, Japan.

Azusa Kayamoto (A)

Department of Rehabilitation, Nagoya University Hospital, Nagoya 466-8560, Japan.

Chiaki Terai (C)

Department of Rehabilitation, Nagoya University Hospital, Nagoya 466-8560, Japan.

Shusuke Nojiri (S)

Department of Rehabilitation, Nagoya University Hospital, Nagoya 466-8560, Japan.

Yuki Fugane (Y)

Department of Rehabilitation, Nagoya University Hospital, Nagoya 466-8560, Japan.

Tomohiro Mori (T)

Department of Rehabilitation, Nagoya University Hospital, Nagoya 466-8560, Japan.

Motoki Nagaya (M)

Department of Rehabilitation, Nagoya University Hospital, Nagoya 466-8560, Japan.

Masato Kako (M)

Department of Rehabilitation, Toyota Memorial Hospital, Toyota 471-8513, Japan.

Hiroki Iida (H)

Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.

Yusuke Osawa (Y)

Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.

Yasuhiko Takegami (Y)

Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.

Yoshihiro Nishida (Y)

Department of Rehabilitation, Nagoya University Hospital, Nagoya 466-8560, Japan.
Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH